European Medicines Agency Begins Review of New Lyme Disease Vaccine
European Union (E.U.) officials will begin the study and review process for Pfizer and Valneva’s vaccine targeting Lyme disease, the world’s most common tick-borne illness. There is currently no commercially approved Lyme disease vaccine.1 2 Pfizer, along with French-Swiss pharmaceutical company Valneva say trials have shown 70 percent efficacy in people ages five and older […]
Kindergarten Vaccine Exemptions in U.S. Increase, But Vaccine Uptake Rates Decline Only Slightly
The percentage of children entering kindergarten with exemptions from required vaccines increased during the 2025-2026 school year, according to data from the U.S. Centers for Disease Control and Prevention (CDC) but vaccine uptake rates for children only declined slightly. The national vaccine exemption rate rose to 4.2 percent, up from 3.6 percent last year. The […]
Despite Safety Concerns, FDA Approves Moderna’s mRNA Flu Shot
On Aug. 5, 2026, the U.S. Food and Drug Administration (FDA) approved Moderna’s seasonal flu shot, mFLUSIVA (mRNA-1010), making it the first messenger RNA platform for seasonal influenza in the United States. The decision permits health care providers to use mRNA technology for annual influenza vaccination in eligible age groups.1 FDA regulators approved mFLUSIVA to […]
Texas Attorney General Investigates AAP’s Financial Ties to Childhood Vaccine Recommendations
When Texas Attorney General Ken Paxton launched a wide-sweeping investigation into financial incentives tied to childhood vaccinations in January, his office issued more than twenty civil investigative demands to pediatric providers, insurance companies, and vaccine manufacturers across the country. Seven months later, that investigation has expanded. Paxton’s office has now issued a civil investigative demand […]
Presidential Executive Order on Childhood Vaccines and Autism Issued
On Aug. 10, 2026, the Trump administration issued an executive order revising the childhood vaccine recommendations in the United States. The order calls for recommending that all children be vaccinated against eleven diseases (down from the current 17), including measles, mumps, rubella, diphtheria, tetanus, pertussis, polio, Haemophilus influenzae type B, pneumococcal disease, human papillomavirus, and […]
Johnson & Johnson Agrees to Pay $5.5 Billion to Resolve Talcum Powder Cancer Litigation
Johnson & Johnson (J&J) announced on July 27, 2026 that it had reached a proposed settlement to resolve approximately 76,000 talcum powder ovarian cancer lawsuits that had accumulated in federal and state courts over more than a decade of litigation. The company committed $5.5 billion toward the resolution, with its first payment not to exceed […]